Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/11/7/883/19478697/11-7-883.pdf
Reference8 articles.
1. An analysis of 1539 patients with cancer of unknown primary site;Altman;Cancer,1986
2. Treatment of patients with carcinoma of unknown primary site;Hainsworth;N Engl J Med,1993
3. Cisplatin based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site, results of a 12-year experience;Hainsworth;J Clin Oncol,1992
4. Randomised trial comparing epirubicin, cisplatin, and fluorouracil versus fluoroura-cil, doxorubicin, and methotrexate in advanced oesophagogastric cancer;Webb;J Clin Oncol,1997
5. A phase II study of continuous infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer;Evans;Br J Cancer,1996
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary;Frontiers in Oncology;2023-07-10
2. CUP – Internistische Therapie bei ungünstigem Risikoprofil;Der Onkologe;2012-12-19
3. Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis;British Journal of Cancer;2012-11-22
4. Management of “unfavourable” carcinoma of unknown primary site: Synthesis of recent literature;Critical Reviews in Oncology/Hematology;2012-11
5. Epirubicin, Cisplatin, and Fluorouracil (ECF) Regimen;Hospital Pharmacy;2009-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3